Logo image of DLB

DOLBY LABORATORIES INC-CL A (DLB) Stock Fundamental Analysis

NYSE:DLB - New York Stock Exchange, Inc. - US25659T1079 - Common Stock - Currency: USD

75.17  -0.51 (-0.67%)

After market: 75.17 0 (0%)

Fundamental Rating

7

Overall DLB gets a fundamental rating of 7 out of 10. We evaluated DLB against 282 industry peers in the Software industry. Both the health and profitability get an excellent rating, making DLB a very profitable company, without any liquidiy or solvency issues. DLB is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

DLB had positive earnings in the past year.
DLB had a positive operating cash flow in the past year.
Each year in the past 5 years DLB has been profitable.
In the past 5 years DLB always reported a positive cash flow from operatings.
DLB Yearly Net Income VS EBIT VS OCF VS FCFDLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

DLB has a better Return On Assets (7.95%) than 82.27% of its industry peers.
DLB's Return On Equity of 9.97% is fine compared to the rest of the industry. DLB outperforms 78.01% of its industry peers.
DLB's Return On Invested Capital of 8.44% is amongst the best of the industry. DLB outperforms 83.33% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for DLB is below the industry average of 12.28%.
The 3 year average ROIC (8.02%) for DLB is below the current ROIC(8.44%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 7.95%
ROE 9.97%
ROIC 8.44%
ROA(3y)7.33%
ROA(5y)7.98%
ROE(3y)9.1%
ROE(5y)9.75%
ROIC(3y)8.02%
ROIC(5y)8.2%
DLB Yearly ROA, ROE, ROICDLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

DLB has a better Profit Margin (19.44%) than 87.23% of its industry peers.
DLB's Profit Margin has been stable in the last couple of years.
DLB has a better Operating Margin (21.44%) than 89.36% of its industry peers.
DLB's Operating Margin has declined in the last couple of years.
DLB has a better Gross Margin (88.92%) than 96.10% of its industry peers.
DLB's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 21.44%
PM (TTM) 19.44%
GM 88.92%
OM growth 3Y-7.9%
OM growth 5Y-2.56%
PM growth 3Y-5.31%
PM growth 5Y0%
GM growth 3Y-0.33%
GM growth 5Y0.44%
DLB Yearly Profit, Operating, Gross MarginsDLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

9

2. Health

2.1 Basic Checks

DLB has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, DLB has less shares outstanding
Compared to 5 years ago, DLB has less shares outstanding
DLB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
DLB Yearly Shares OutstandingDLB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
DLB Yearly Total Debt VS Total AssetsDLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

An Altman-Z score of 8.83 indicates that DLB is not in any danger for bankruptcy at the moment.
The Altman-Z score of DLB (8.83) is better than 81.56% of its industry peers.
DLB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.83
ROIC/WACC0.78
WACC10.86%
DLB Yearly LT Debt VS Equity VS FCFDLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

A Current Ratio of 3.04 indicates that DLB has no problem at all paying its short term obligations.
DLB has a better Current ratio (3.04) than 78.01% of its industry peers.
DLB has a Quick Ratio of 2.96. This indicates that DLB is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 2.96, DLB is doing good in the industry, outperforming 78.37% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.04
Quick Ratio 2.96
DLB Yearly Current Assets VS Current LiabilitesDLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

DLB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.94%, which is quite good.
Measured over the past years, DLB shows a quite strong growth in Earnings Per Share. The EPS has been growing by 9.26% on average per year.
DLB shows a small growth in Revenue. In the last year, the Revenue has grown by 4.03%.
The Revenue has been growing slightly by 0.51% on average over the past years.
EPS 1Y (TTM)14.94%
EPS 3Y1.08%
EPS 5Y9.26%
EPS Q2Q%5.51%
Revenue 1Y (TTM)4.03%
Revenue growth 3Y-0.2%
Revenue growth 5Y0.51%
Sales Q2Q%1.38%

3.2 Future

The Earnings Per Share is expected to grow by 6.54% on average over the next years.
The Revenue is expected to grow by 4.92% on average over the next years.
EPS Next Y5.52%
EPS Next 2Y5.74%
EPS Next 3Y6.54%
EPS Next 5YN/A
Revenue Next Year5.04%
Revenue Next 2Y4.84%
Revenue Next 3Y4.92%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DLB Yearly Revenue VS EstimatesDLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B
DLB Yearly EPS VS EstimatesDLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

6

4. Valuation

4.1 Price/Earnings Ratio

DLB is valuated rather expensively with a Price/Earnings ratio of 18.79.
DLB's Price/Earnings ratio is rather cheap when compared to the industry. DLB is cheaper than 82.27% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.30, DLB is valued a bit cheaper.
With a Price/Forward Earnings ratio of 17.69, DLB is valued on the expensive side.
DLB's Price/Forward Earnings ratio is rather cheap when compared to the industry. DLB is cheaper than 81.91% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of DLB to the average of the S&P500 Index (21.76), we can say DLB is valued inline with the index average.
Industry RankSector Rank
PE 18.79
Fwd PE 17.69
DLB Price Earnings VS Forward Price EarningsDLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

83.33% of the companies in the same industry are more expensive than DLB, based on the Enterprise Value to EBITDA ratio.
DLB's Price/Free Cash Flow ratio is rather cheap when compared to the industry. DLB is cheaper than 83.69% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.5
EV/EBITDA 18.13
DLB Per share dataDLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates DLB does not grow enough to justify the current Price/Earnings ratio.
DLB has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)3.41
PEG (5Y)2.03
EPS Next 2Y5.74%
EPS Next 3Y6.54%

6

5. Dividend

5.1 Amount

DLB has a Yearly Dividend Yield of 1.75%.
DLB's Dividend Yield is rather good when compared to the industry average which is at 33.28. DLB pays more dividend than 95.74% of the companies in the same industry.
Compared to the average S&P500 Dividend Yield of 2.37, DLB is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.75%

5.2 History

The dividend of DLB is nicely growing with an annual growth rate of 9.47%!
DLB has been paying a dividend for at least 10 years, so it has a reliable track record.
DLB has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)9.47%
Div Incr Years10
Div Non Decr Years10
DLB Yearly Dividends per shareDLB Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

DLB pays out 47.03% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of DLB is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP47.03%
EPS Next 2Y5.74%
EPS Next 3Y6.54%
DLB Yearly Income VS Free CF VS DividendDLB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
DLB Dividend Payout.DLB Dividend Payout, showing the Payout Ratio.DLB Dividend Payout.PayoutRetained Earnings

DOLBY LABORATORIES INC-CL A

NYSE:DLB (7/11/2025, 8:04:00 PM)

After market: 75.17 0 (0%)

75.17

-0.51 (-0.67%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-01 2025-05-01/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners95.73%
Inst Owner Change-0.02%
Ins Owners1.09%
Ins Owner Change0.13%
Market Cap7.22B
Analysts82.5
Price Target99.45 (32.3%)
Short Float %2.04%
Short Ratio3.18
Dividend
Industry RankSector Rank
Dividend Yield 1.75%
Yearly Dividend1.2
Dividend Growth(5Y)9.47%
DP47.03%
Div Incr Years10
Div Non Decr Years10
Ex-Date05-13 2025-05-13 (0.33)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.95%
Min EPS beat(2)4.74%
Max EPS beat(2)7.16%
EPS beat(4)4
Avg EPS beat(4)11.54%
Min EPS beat(4)4.74%
Max EPS beat(4)19.15%
EPS beat(8)7
Avg EPS beat(8)11.13%
EPS beat(12)10
Avg EPS beat(12)13.43%
EPS beat(16)13
Avg EPS beat(16)13.56%
Revenue beat(2)1
Avg Revenue beat(2)-0.34%
Min Revenue beat(2)-2.79%
Max Revenue beat(2)2.11%
Revenue beat(4)1
Avg Revenue beat(4)-0.69%
Min Revenue beat(4)-2.79%
Max Revenue beat(4)2.11%
Revenue beat(8)2
Avg Revenue beat(8)-0.68%
Revenue beat(12)4
Avg Revenue beat(12)-0.26%
Revenue beat(16)5
Avg Revenue beat(16)-0.72%
PT rev (1m)0%
PT rev (3m)-2.5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-10.08%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.46%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.13%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.09%
Valuation
Industry RankSector Rank
PE 18.79
Fwd PE 17.69
P/S 5.47
P/FCF 18.5
P/OCF 17.23
P/B 2.81
P/tB 4.41
EV/EBITDA 18.13
EPS(TTM)4
EY5.32%
EPS(NY)4.25
Fwd EY5.65%
FCF(TTM)4.06
FCFY5.41%
OCF(TTM)4.36
OCFY5.8%
SpS13.74
BVpS26.79
TBVpS17.04
PEG (NY)3.41
PEG (5Y)2.03
Profitability
Industry RankSector Rank
ROA 7.95%
ROE 9.97%
ROCE 10.21%
ROIC 8.44%
ROICexc 10.9%
ROICexgc 19.36%
OM 21.44%
PM (TTM) 19.44%
GM 88.92%
FCFM 29.57%
ROA(3y)7.33%
ROA(5y)7.98%
ROE(3y)9.1%
ROE(5y)9.75%
ROIC(3y)8.02%
ROIC(5y)8.2%
ROICexc(3y)11.36%
ROICexc(5y)12.88%
ROICexgc(3y)17.78%
ROICexgc(5y)19.47%
ROCE(3y)9.71%
ROCE(5y)9.93%
ROICexcg growth 3Y-12.75%
ROICexcg growth 5Y-4.71%
ROICexc growth 3Y-18.76%
ROICexc growth 5Y-8.2%
OM growth 3Y-7.9%
OM growth 5Y-2.56%
PM growth 3Y-5.31%
PM growth 5Y0%
GM growth 3Y-0.33%
GM growth 5Y0.44%
F-Score7
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 34.31%
Cap/Sales 2.17%
Interest Coverage 250
Cash Conversion 114.34%
Profit Quality 152.14%
Current Ratio 3.04
Quick Ratio 2.96
Altman-Z 8.83
F-Score7
WACC10.86%
ROIC/WACC0.78
Cap/Depr(3y)47.88%
Cap/Depr(5y)55.27%
Cap/Sales(3y)3.14%
Cap/Sales(5y)3.93%
Profit Quality(3y)140.69%
Profit Quality(5y)133.53%
High Growth Momentum
Growth
EPS 1Y (TTM)14.94%
EPS 3Y1.08%
EPS 5Y9.26%
EPS Q2Q%5.51%
EPS Next Y5.52%
EPS Next 2Y5.74%
EPS Next 3Y6.54%
EPS Next 5YN/A
Revenue 1Y (TTM)4.03%
Revenue growth 3Y-0.2%
Revenue growth 5Y0.51%
Sales Q2Q%1.38%
Revenue Next Year5.04%
Revenue Next 2Y4.84%
Revenue Next 3Y4.92%
Revenue Next 5YN/A
EBIT growth 1Y18.66%
EBIT growth 3Y-8.08%
EBIT growth 5Y-2.06%
EBIT Next Year27.7%
EBIT Next 3Y13.2%
EBIT Next 5YN/A
FCF growth 1Y12.13%
FCF growth 3Y-8.91%
FCF growth 5Y6.77%
OCF growth 1Y8.92%
OCF growth 3Y-9.93%
OCF growth 5Y-0.03%